2017 年作为新零售元年,“消费升级”关键词热度在该年达到顶峰,同比 2016 年增长 279%。截至 2018年 8月,“消费升级”搜索热度依然未减,是 2016年全年该词搜索热度的 2倍。反观 .
2021-06-30
17页




5星级
海伦司小酒馆在中国酒馆行业连续三年保持规模最大的市场领先定位。截至2021年3月22日,海伦司小酒馆门店共计372家,覆盖83个城市。官方微信、抖音及微博官方账号累计粉丝已超570万,视频累计播放超1.
2021-06-24
25页




5星级
报告摘要 ABSTRACT投资概览:2021年,中国CVC市场共披露1694起投资案例,相比2020年增幅达20.4%。行业分布方面,医疗健康、智能制造、企业服务分别以265、243、241起投资案例.
2021-05-01
53页




5星级
近年来,我们看到越来越多的资金流入ESG投资。1在2020年上半年,随着新冠病毒危机影响金融市场,MSCI ACWI ESG所有标准股指的表现都超过了其市值基准。这种优异表现从何而来?我们用两种方法研究了这个问题。首先,我们考察了MSCI ESG股票指数的表现。其次,我们使用ESG全面评级覆盖的最长时间,研究了MSCI ACWI指数中ESG评级高的和ESG评级低的tercs的表现。利用MSCI全球股票因素模型 ESG (GEMLTESG)因素模型,我们在两种类型的分析中发现,中国股市的超额表现部分归因于其他风格因素。与此同时,我们发现,ESG对业绩的贡献,是其他因素无法完全解释的。
2021-04-01
17页




5星级
伦敦银行间同业拆借利率(LIBOR)作为基准利率的未来充满不确定性,且在2021年后无法得到保证。监管和咨询机构发现,LIBOR存在缺陷,因为它没有交易数据的支持,基于判断,并存在操纵的可能性。在全球.
2021-03-23
40页




5星级
自2019年以来,孤儿症/罕见疾病一直是所获投资最多的神经学适应症我们观察到,2019年至2020年间,对专注于神经学的孤儿症/罕见疾病适应症(NOR)公司的投资有小幅增长。我们利用CipherBio.
2021-03-15
37页




5星级
润汇出、征收补偿等。当企业认为自身权益受到东道国政府侵害时,可以依据投资协定中的相关内容寻求第三方仲裁,如诉诸国际投资争端解决中心(ICSID)。尽管仲裁机构没有强制执行裁决的权力,但各国政府通常遵守.
2021-03-15
17页




5星级
全球绿地投资概况-电力、燃气等供应业排名第一绿地投资又称创建投资,是指跨国公司等投资主体在东道国境内依照东道国的法律设置的部分或全部资产所有权归外国投资者所有的企业。根据联合国统计数据,2019年全球.
2021-03-12
97页




5星级
MM 2021 Global Strategy Outlook Keep Faith in the Recovery AV-shaped recovery, greater clarity on vaccines and continued policy support point to early-cycle dynamics and a supportive outlook for risk assets. Keep the faith, trust the recovery, and overweight equities and credit against government bonds and cash. Due to the nature of the fixed income market, the issuers or bonds of the issuers recommended or discussed in this report may not be continuously followed. Accordingly, investors must regard this report as providing stand-alone analysis and should not expect continuing analysis or additional reports relating to such issuers or bonds of the issuers. Matthew Hornbach, Guneet Dhingra, Tony Small, Koichi Sugisaki, David Adams, James Lord, Sheena Shah, Simon Waever, Jaiparan Khurana, Min Dai, Andres Jaime, Srikanth Sankaran, Vishwas Patkar, Max Blass, Kelvin Pang, Vishwanath Tirupattur, Jay Bacow, James Egan, Michael Zezas and Barbara Boyake are fixed income strategists and are not opining on equity securities. Their views are clearly delineated. Morgan Stanley does and seeks to do business with companies covered in Morgan Stanley Research. As a result, investors should be aware that the firm may have a conflict of interest that could affect the objectivity of Morgan Stanley Research. Investors should consider Morgan Stanley Research as only a single factor in making their investment decision. For analyst certification and other important disclosures, refer to the Disclosure Section, located at the end of this report. November 15, 2020 06:15 PM GMT MM 2021 Global Strategy Outlook Keep Faith in the Recovery Its a recovery keep the faith: Rising COVID-19 cases are a risk, but keep the faith. We think this global recovery is sustainable, synchronous and supported by policy, following much of the normal post-recession playbook. Overweight equities and credit against cash and govern- ment bonds, and sell USD. Be patient in commodities; we think that index-level returns will be back-loaded. Global equities strong growth, strong returns: Across regions, we see 25-30% EPS growth and double-digit total returns through end-2021. We are O/W cyclicals and U/W defensives across regions, and expect US small-caps to outperform large-caps. We think that EM/APxJ equities will lag DM slightly, but upgrade India to O/W. We see the S top currencies include INR, IDR, RUB, ZAR and BRL. Corporate credit early-cycle crossroads: Across all regions, we favor HY over IG and posi- tion for compression themes across the ratings buckets, and favor leveraged loans over HY bonds. We forecast above-average excess returns across major cash indices. Securitized credit dont change the channel: With the Fed on hold until late 2023 and a continued V-shaped recovery, investors should follow the portfolio balance channel. We rec- ommend investors go down in quality and up in risk across the securitized space; we expect higher-yielding, lower-rated sectors to outperform less risky assets. We like long CMBX.11 BBB- outright. Commodities macro versus fundamentals: Stronger growth, higher inflation and a weaker dollar are offset by bottom-up fundamentals that remain soft in most markets. Supply/demand dynamics are supportive in copper and natural gas, and more negative in oil and iron ore. 2021 may be a turning point for gold, and we revise our price forecast lower. For individual investors, our market outlook should be seen in the con- text of a long investment horizon that is underpinned by a compre- hensive financial plan. Your clients financial plan should reflect the goals they are looking to achieve over time and a disciplined approach to asset allocation, saving and withdrawals. MM Contributors MORGAN STANLEY *Global Equity ERP is a market cap-weighted average of our US, Europe, Japan and EM long-term expected risk premium forecasts. CLO AAA is a new issue series. The lesson from 2010, which we think also applies to 2021, is that the cycle usually wins out. We are strong believers that markets care more about rate of change than level and, following a recession, these cyclical tailwinds are powerful. We forecast 6.4%Y global real GDP growth next year, 25-30% earnings growth across major mar- kets and significant declines in corporate leverage. Yes, this is partly because these are coming off weak levels, but we think that the effect will be powerful all the same. Key investment ideas 2020 witnessed once-in-a-century swings in the economy, policy and markets. 2021 will bring more normality. Trust the recovery, and the post-recession playbook. O/W global equities and credit, funded by an U/W in government bonds and cash. Commodities lag other risk assets, as mixed fundamentals drive dispersion. USD to weaken, volatility to fall. Andrew Sheets Andrew.S 44 20 7677-2905 Morgan Stanley Note: We show real GDP and headline inflation here. Our cycle model paints a similar picture. Data that are below-average but improving tend to support equities and credit doing somewhat better than their valuations would imply. Our economists call for higher inflation gives a similar answer; inflation that is below trend, but rising, tends to support a compression of risk premium. Exhibit 5: Equities and credit do the best when data are below-average and improving (repair phase) DownturnRepair*RecoveryExpansion EQUITIES S Note: Based on our US cycle indicator. Data from 1985 where available. *Repair phase returns are based on forward returns in repair phase, post-trough. Post-recession, early-cycle environments also frequently benefit from favorable technicals. And again, we think that this applies today. Uncertainty over public health and the political environment has helped to keep money on the sidelines. Ongoing QE by global central banks continues to restrict net supply. The recent jump in sentiment is a little concerning, but ultimately we think that the other techncials win out. Exhibit 6: Technicals remain largely favorable 68% 89% 27% 94% 64% 92% 76% 100% 0% 0% 0% 0% 0% 0% 0% 100% 100% 100% 100% 100% 100% AAII Net Bulls (4WMA) S Note: For equities we show our long-term expected risk premium forecasts, and for credit we show loss-adjusted spread. 10Y vol is realized vol of monthly returns. The dotted line shows the annualized return for S Note: Commodity FX here is the average 15-year percentile of AUD, CAD and NOK versus USD. Debate #2: The virus and a K-shaped recovery A second concern with echoes of 2010 is whether the recovery is sus- tainable. Following the GFC, worries centered on high levels of con- sumer and corporate debt, weakness in the labor market and whether the financial crisis had shifted behavior permanently. Today, worries center on a highly unequal recovery, high levels of government debt, weakness in the labor market and whether the pandemic has shifted behavior permanently. Similar to 2010, we think that our economic forecasts see these chal- lenges as serious, but surmountable. Fiscal and monetary stimulus have been larger than what followed the GFC, and so far the recovery has been faster. A successful vaccine will be important, but Morgan Stanleys biotechnology team is optimistic, especially with recent announcements. Rising COVID-19 cases suggest some slowing in 4Q20 and 1Q21, and could drive tactical weakness. But through the end of next year, our key economic call is that the global recovery will be sustainable. Use near-term weakness to raise strategic exposures. Allocations and key trades Our strategic allocations are based on the combination of cycle-ad- justed risk premiums and Morgan Stanley strategists 12-month fore- casts. Both suggest above-average risk-adjusted returns for equities and credit over the next 12 months. Conversely, we see yields rising and underperforming the forwards, and expect US duration to underper- form first. We recommend that investors hold modest overweights in global equities and credit, and modest underweights in cash and gov- ernment bonds ( Exhibit 47 ). In currencies, we see modest USD weak- ness. We think that commodity prices rise, but our forecasts see this strength as back-loaded, and with high dispersion given an uneven supply/demand dynamic. For now, we prefer to allocate exposure towards equities and credit. Equities: Improving earnings growth should offset modest de-rating across markets, a usual handoff for equities following a recession. We prefer DM over EM and our sector and style preferences remain skewed to early-cycle, cyclical exposure. We like US small-caps over large-caps, India, and Australia over Taiwan. Government bonds: Given how much dovishness is in the price, we think that US and EU yields can rise modestly and underperform the forwards as the economy improves. Long US 5s30s steepeners and sell UST 30y versus Bunds and ACGBs 30y. FX: Early-cycle recovery and hope for a vaccine should see USD weaken modestly by 3% in 2021. EMFX and commodity currencies will likely see the biggest uplift. Long cyclical G10 FX (SEK, NZD. NOK) versus USD. Credit: We think that we remain in a supportive, early-cycle environ- ment for credit, and expect high yield outperformance as the economy heals. Sell protection in CDX HY versus CDX IG. We are also bullish on Asia credit. Commodities: A benign macro backdrop of recovery and a weaker dollar is offset by bearish micro fundamentals like high inventories and oversupply, leading to a mixed picture for commodities overall. The one market where bottom-up demand-supply dynamics are aligned with the cycle is copper; long copper versus gold, sell Brent 3M calls. Volatility: The gap between equity/credit and FX/rate volatility remains extreme, and we think that this can narrow as global eco- nomic conditions normalize. M MORGAN STANLEY RESEARCH9 M Exhibit 9: Our framework likes equities and credit US8.2.0.1%0.5 1% Europe11.9.3.0%0.7 2% Japan9.1.5%9.9%0.5 1% EM14.0%7.9.9%0.6 0% Treasuries1.2%-2.7%-0.9%-0.2-3% Bunds0.7%-3.1%-0.5%-0.1-1% JGBs0.0%0.5%0.4%0.2 0% EM Local*-0.6%-0.7%-0.1 0% US IG3.9%2.5%3.2%0.7 US HY9.1%5.9%7.5%1.1 EUR IG2.5%1.2%1.9%0.9 EUR HY9.7%4.8%7.3%1.2 EM $6.8%4.8%5.8%0.8 0% Securitised-1.1%1.1%0.7 1% Commodities- 0.6% 0.5% 0.0 0% Legend: 1 EquitiesBondsCredit 1% 2% (D) MS Asset Allocation vs Benchmark Top-Down Expected Returns Bottom-Up 12M Outlook* Avg (A, B - Cash)(C)/ Vol Cycle-Adj Returns MS Base Case Rtn Forecast Forecast Excess Rtn Framework Expected Rtn/ Vol (C) Top-Down Risk Premium Cycle Boost/Drag (A)(B) (LT Rtns): LT Z-score 0.5 (Cyc): Phase with best returns for the asset (LT Rtns): LT Z-score EM: We continue to prefer DM to EM and model similar upside for US, Europe and Japan over the next 12 months. We expect China outperformance versus EM ex China to moderate (we continue to prefer A-shares) and upgrade India to O/W. Recommendations: O/W cyclicals (e.g., materials and reopening plays) and financials in the US and Europe; cautious on expensive defensive/growth names; downgrade Asia tech hardware to E/W. Global equities: Strong growth, strong returns Equities US Europe Japan EM From late-cycle to early-cycle in 12 months.via a pandemic: Looking back at what we wrote in our 2020 global equity outlook last November highlights just how much the investment landscape has changed over the intervening 12 months. Last year our concerns about a late-cycle economic backdrop, elevated valuations and heightened investor optimism translated into materially below-con- sensus EPS expectations and subdued single-digit prospective returns. While we never predicted the subsequent pandemic, its con- sequences leave us in a very different place today. We believe that we have now transitioned to an early-cycle environment, which implies strong profit growth that we believe is not yet priced in to markets despite the sharp rally in the last two weeks ( Exhibit 14 ). 25-30% global EPS growth likely in 2021: Whenever economies move out of recession, there is always concern about the speed and strength of recovery, but the degree of uncertainty here is arguably higher than normal, given the combination of an unprecedented pan- demic against record monetary and fiscal stimulus. Although the ongoing increase in COVID-19 cases in Europe and the US may lead to some near-term weakness in economic activity, this is very unlikely to derail a strong profit rebound over the next 12 months, in our opinion. Instead, strong nominal GDP growth next year implies a size- able acceleration in revenue growth, which should be turbocharged by impressive operating leverage. As illustrated in Exhibit 15 , our top-down EPS growth forecasts for all regions are 25-30% for next year, with further double-digit growth expected in 2022 too. Together, these estimates imply MSCI ACWI EPS growth of 27% for 2021, which would represent the second-best out-turn in 30 years (after 2010). Exhibit 14: We forecast solid equity returns across all DM regions over the next 12 months BullBaseBearBullBaseBear 4,1753,9003,3753,7003,3502,900 18%-5%5%-5%-18% 1,8701,7301,4101,8101,5801,280 20%-10%1%-18% 2,0001,8701,3001,8301,5501,200 16%8%-25%6%-10%-30% 1,4001,2509001,3001,000790 18%6%-24%-15%-33% (% from current levels) New Target Price - December 2021Old Target Price - June 2021 Index Current Price S for the latter to catch up to the former would require c.35% outperformance. Alternatively, we can flip this logic around and say that asset markets are pricing in a sub-50 global PMI instead of the current 53.3. Exhibit 16: Unusual lag between the YoY change in MSCI World and that of global PMI. -5 -4 -3 -2 -1 0 1 2 3 4 -25 -20 -15 -10 -5 0 5 10 15 20 25 30 35 Jan-11Jul-12Jan-14Jul-15Jan-17Jul-18Jan-20 MSCI World YoY vs. Global Composite PMI YoY (%) MSCI WorldPMI (RHS) DEC-19 Source: MSCI, Markit, Morgan Stanley Research Exhibit 17: and the gap is even wider if we compare PMI trends to the relative return of stocks versus bonds -4 -3 -2 -1 0 1 2 3 4 -40 -30 -20 -10 0 10 20 30 40 50 Jan-11Jul-12Jan-14Jul-15Jan-17Jul-18Jan-20 Total Return of MSCI World vs US 10YPMI (RHS) DEC-19 Stocks vs. Bonds Relative Return vs. Global Comp PMI (%) Source: MSCI, Markit, Morgan Stanley Research Sustained policy support into the recovery. The unique cause of the 2020 recession has meant that policy-makers have been given unprecedented latitude to respond without meaningful pushback, whether that is record peacetime fiscal deficits or large-scale quantita- tive easing (G3 central banks have expanded their balance sheets by c.US$7 trillion year-to-date). While this has proved critical in sup- porting asset markets through this year, what may also prove unique is its persistence into the recovery, with our economists expecting fur- ther fiscal and monetary stimulus during 2021. In their recen
2020-12-08
63页




5星级
12020 海南资本市场竞争力报告:力压山东湖南湖北,资产证券化率跻身全国海南资本市场竞争力报告:力压山东湖南湖北,资产证券化率跻身全国 12 强强时代商学院研究员时代商学院研究员 孙华秋孙华秋党的十.
2020-12-03
11页




5星级
2020年新发Smart Beta ETF产品共5只,管理规模约为1.98亿美元。截至年底固定收益Smart Beta ETF共71只(不含主动管理),规模约206.24亿美元,同比增长38.7%,规.
2020-12-01
22页




5星级
2020年的主要发展新冠疫情占据了2020年的主导地位。面对这一前所未有的挑战,中英两国仍找到了合作机会。例如,英国中国商会(CCCUK)向英国捐赠了超过435万件医疗物资。这些医疗物资通过英国国家医.
2020-12-01
18页




5星级
明树数据 民企与国企融资现状对比报告 明树数据 民企与国企融资现状对比报告 目目 录录 _Toc38976033 I. 量:规模不在同一量级,分化愈演愈烈 . 2 1、2019 年至今,国企民企公司债.
2020-12-01
12页




5星级
2020年11月 高瓴资本集团 可持续性价值投资影响力报告 可持续性价值投资战略 可持续性价值投资管理 1 2 可持续性价值投资创造 01 创始人致辞 高瓴概览 50 员工权益 52 理想的工作场所 .
2020-11-19
39页




5星级
2020年四季度大类资产配置报告 研 究 员 : 陆 胜 斌 、 陶 金 、 顾 慧 君 苏 宁 金 融 研 究 院 投 资 策 略 研 究 中 心 2 0 2 0 年 1 0 月 目录 CONTEN.
2020-10-26
37页




5星级
请务必阅读正文之后的信息披露和法律声明 宏观研究宏观研究 证券证券研究研究报告报告 宏观专题报告宏观专题报告 2020 年年 08 月月 14 日日 相关研究相关研究 Table_ReportInf.
2020-08-14
20页




5星级
科创板解禁修复期与创业板注册制躁动期共振科创板解禁修复期与创业板注册制躁动期共振 科创板系列研究(二十一)科创板系列研究(二十一) 分析师:分析师: 王德伦S0190516030001 李美岑S019.
2020-08-05
24页




5星级
证券研究报告 请务必阅读正文之后的免责条款 优质赛道优质赛道细分龙头,细分龙头,增长强劲优势显著增长强劲优势显著 比音勒芬(002832)投资价值分析报告2020.8.4 中信证券研究部中信证券研究.
2020-08-05
52页




5星级
请务必阅读正文之后的免责条款部分 全球视野全球视野 本土智慧本土智慧 行业研究行业研究 Page 1 证券研究报告证券研究报告深度报告深度报告 信息技术信息技术 服务器服务器行业行业专题报告专题报告.
2020-08-05
19页




5星级
腾讯研究院:2026从超级个体到超级团队:AI时代组织变革的涌现路径研究报告(82页).pdf
前哨科技:2026年中国企业AI应用进程与场景落地研究报告(52页).pdf
世界经济论坛:2026年十大新兴技术报告(英文版)(49页).pdf
中国新一代人工智能发展战略研究院:中国新一代人工智能科技产业发展报告2026(65页).pdf
中国智能计算产业联盟:2026全球AI算力发展研究报告(93页).pdf
中国工业互联网研究院:Token 驱动智能经济研究报告(2026年)(65页).pdf
清华大学:2026年Agent-to-Agent (A2A)研究报告(104页).pdf
毕马威:2026全球技术报告(40页).pdf
中国信通院:企业级智能体技术与应用研究报告(2026年)(55页).pdf
HCR慧辰股份:2026年中国具身智能产业系列研究报告-人形机器人篇(25页).pdf